Declaración de la Sociedad Chilena de Reumatología frente a la autorización otorgada por el Instituto de Salud Pública (ISP) de medicamentos biosimilares / Statement of the Chilean Society of Rheumathology against the authorization issued by the Institute of Public Health (ISP) for biosimilar drugs
Rev. chil. reumatol
;
26(3): 218-219, 2010.
Article
in Spanish
| LILACS
| ID: lil-572143
Subject(s)
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Biological Products
/
Pharmaceutical Preparations
/
Drug Approval
Type of study:
Prognostic study
Limits:
Humans
Country/Region as subject:
South America
/
Chile
Language:
Spanish
Journal:
Rev. chil. reumatol
Journal subject:
Rheumatology
Year:
2010
Type:
Article
Similar
MEDLINE
...
LILACS
LIS